Corporate DisclosureSQURPHARMA
SQURPHARMA Corporate Disclosure — 20 August 2017
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 20 August 2017. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
The Company has informed that a total of 2,62,47,368 shares of late Sponsor Dr. Kazi Harunar Rashid has been transmitted to his legal heirs according to the succession certificate issued by the Honorable Court: i) 1,31,23,684 shares to Mr. Kazi Iqbal Harun (son, Director of the Company), ii) 65,61,842 shares to Mrs. Nilufar Ferdous (daughter) and iii) 65,61,842 shares to Mrs. Nargis Ferdous (daughter).
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf0d5a6b00004005ed40
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.